Bouilly Justine, Beau Isabelle, Barraud Sara, Bernard Valérie, Azibi Kemal, Fagart Jérôme, Fèvre Anne, Todeschini Anne Laure, Veitia Reiner A, Beldjord Chérif, Delemer Brigitte, Dodé Catherine, Young Jacques, Binart Nadine
Inserm 1185 (J.B., I.B., S.B., J.F., J.Y., N.B.), Le Kremlin-Bicêtre, Université Paris-Saclay, Faculté de Médecine Paris Sud, 94270 Le Kremlin-Bicêtre, France; Service de Biochimie et Génétique Moléculaire (K.A., C.B., C.D.), Hôpital Cochin, AP-HP, Université Paris-Descartes, 75004 Paris, France; Service d'Endocrinologie-Diabète-Nutrition (A.F., B.D.), CHU de Reims-Hôpital Robert-Debré, 51100 Reims, France; Institut Jacques Monod (A.L.T., R.A.V.), Université Paris Diderot-PARIS 7/CNRS UMR7592, 75013 Paris, France; and Service d'Endocrinologie et des Maladies de la Reproduction (J.Y.), APHP, Hôpital de Bicêtre, 94270 Le Kremlin-Bicêtre, France.
J Clin Endocrinol Metab. 2016 Dec;101(12):4541-4550. doi: 10.1210/jc.2016-2152. Epub 2016 Sep 7.
Idiopathic primary ovarian insufficiency (POI) is a major cause of amenorrhea and infertility. POI affects 1% of women before age 40 years, and several genetic causes have been reported. To date, POI has been considered a monogenic disorder.
The aim of this study was to identify novel gene variations and to investigate if individuals with POI harbor mutation in multiple loci.
One hundred well-phenotyped POI patients were systematically screened for variants in 19 known POI loci (and potential candidate genes) using next-generation sequencing.
At least one rare protein-altering gene variant was identified in 19 patients, including missense mutations in new candidate genes, namely SMC1β and REC8 (involved in the cohesin complex) and LHX8, a gene encoding a transcription factor. Novel or recurrent deleterious mutations were also detected in the known POI candidate genes NOBOX, FOXL2, SOHLH1, FIGLA, GDF9, BMP15, and GALT. Seven patients harbor mutations in two loci, and this digenicity seems to influence the age of symptom onset.
Genetic anomalies in women with POI are more frequent than previously believed. Digenic findings in several cases suggest that POI is not a purely monogenic disorder and points to a role of digenicity. The genotype-phenotype correlations in some kindreds suggest that a synergistic effect of several mutations may underlie the POI phenotype.
特发性原发性卵巢功能不全(POI)是闭经和不孕的主要原因。POI影响1%的40岁前女性,并且已有多种遗传病因被报道。迄今为止,POI一直被认为是一种单基因疾病。
本研究的目的是鉴定新的基因变异,并调查POI患者是否在多个位点存在突变。
使用下一代测序技术,对100例表型明确的POI患者进行系统筛查,检测19个已知POI位点(以及潜在候选基因)中的变异。
在19例患者中鉴定出至少一种罕见的蛋白质改变基因变异,包括新候选基因SMC1β和REC8(参与黏连蛋白复合体)以及编码转录因子的基因LHX8中的错义突变。在已知的POI候选基因NOBOX、FOXL2、SOHLH1、FIGLA、GDF9、BMP15和GALT中也检测到新的或复发性有害突变。7例患者在两个位点存在突变,这种双基因性似乎影响症状出现的年龄。
POI女性中的遗传异常比以前认为的更常见。几例双基因发现表明POI并非纯粹的单基因疾病,提示双基因性起作用。一些家系中的基因型-表型相关性表明,几种突变的协同效应可能是POI表型的基础。